Cholangiocarcinomas (CCA) are a heterogeneous group of tumors that are classified as intrahepatic, perihilar, or distal according to the anatomic location within the biliary tract …
D Alvaro, GJ Gores, J Walicki, C Hassan… - Journal of …, 2023 - Elsevier
Intrahepatic cholangiocarcinoma (iCCA) develops inside the liver, between bile ductules and the second-order bile ducts. It is the second most frequent primary liver cancer after …
PA Cavallaro, M De Santo, EL Belsito, C Longobucco… - Nanomaterials, 2023 - mdpi.com
Breast cancer represents the most common cancer type and one of the major leading causes of death in the female worldwide population. Overexpression of HER2, a …
MC Bragazzi, R Venere, E Ribichini, F Covotta… - Digestive and Liver …, 2024 - Elsevier
Intrahepatic cholangiocarcinoma is the second most frequent primary liver cancer after hepatocellular carcinoma. According to International Classification of Diseases-11 (ICD-11) …
Highlights•Actionable alterations should be prioritized by using validated rankings for treatment tailoring.•High-throughput genomics could refine drivers and find new targets, mini …
L Colyn, G Alvarez-Sola, MU Latasa, I Uriarte… - Journal of Experimental …, 2022 - Springer
Background Cholangiocarcinoma (CCA) is still a deadly tumour. Histological and molecular aspects of thioacetamide (TAA)-induced intrahepatic CCA (iCCA) in rats mimic those of …
P Gopal, ME Robert, X Zhang - Archives of Pathology & …, 2024 - meridian.allenpress.com
Context.—Cholangiocarcinoma (CCA) is a heterogeneous cancer of the bile duct, and its diagnosis is often challenging. Objective.—To provide insights into state-of-the-art …
A Vingiani, L Agnelli, M Duca, D Lorenzini… - JCO Precision …, 2023 - ascopubs.org
PURPOSE The investigation of multiple molecular targets with next-generation sequencing (NGS) has entered clinical practice in oncology, yielding to a paradigm shift from the …
A Lamarca, T Macarulla - Clinical Cancer Research, 2024 - aacrjournals.org
Biliary tract cancers (BTC) are a heterogeneous group of cancers that continue to present a particularly poor prognosis. BTC treatment is rapidly evolving yet facing many challenges to …